Marketplace Morning Report – "Can the bull market last?"

Date: September 22, 2025
Host: David Brancaccio

Overview

This episode examines the state of the ongoing bull market in the U.S. stock market, recent policy shifts, and changes in government regulations affecting pharmaceuticals and immigration. The discussion is timely against a backdrop of robust stock gains, policy uncertainty, and regulatory shifts under the Trump administration.

Key Discussion Points & Insights

The Bull Market: How Long Can It Last?

• Stock Market Highs:

  • The S&P 500 is up over 15% YTD; Nasdaq up 17% (01:09).
  • Small stocks (Russell 2000) are particularly strong, reaching a record not seen in four years.

• Underlying Fundamentals:

  • Analyst Scott Wren (Wells Fargo Investment Institute) says economic fundamentals, not speculation, are powering gains (01:48).
  • GDP and earnings estimates are on the rise, especially for small-cap companies (01:55).
    • "The market doesn't think there's going to be a recession. GDP estimates are going up. Earnings estimates have gone up for small-cap stocks in particular." – David Brancaccio (01:55)

• Interest Rates’ Role:

  • Recent Federal Reserve rate cuts are helping—particularly small caps, which benefit from lower debt service costs (02:16).

• Investor Sentiment:

  • According to Wells Fargo’s Scott Wren, “...our clients still have considerable amount of cash... they’re not selling stocks, but they’re not jumping in either. The mood does not seem euphoric.” – David Brancaccio (02:34)
  • Sam Stovall (CFRA Research) notes: “There’s not too much expectations that share prices will continue to set new highs." (02:49)
  • Yet skeptics say that because expectations are muted, the market could continue to rise (02:57).
    • “As a result, they probably will.” – Sam Stovall via Mitchell Hartman (02:57)

U.S. Pharmaceutical Advertising Crackdown

• Regulatory Shift:

  • The Trump administration, with HHS Secretary Robert Kennedy Jr., is moving to rein in televised drug ads (05:08).
  • The focus: curb “false and deceptive advertising,” and “turn back the clock” to the pre-1997 era when ads were limited to print and required full risk disclosure (05:54).

• Practical Consequences:

  • TV ads allowed since 1997 with only a “major risk scene” and disclosure of a toll-free number or website address (07:23).
  • The administration wants to force more comprehensive disclosure, emphasizing actual clinical benefits and risks (06:28).
    • "In reality, the major clinical trial found that about half the people had a major response to this drug. So it looks like the FDA is really going to be leaning on drug companies to try to put a finer point on what they tell the public about... how much these drugs are going to change their lives." – Christina Jewett (06:28)

• Legal & Political Obstacles:

  • Pharmaceutical companies are expected to fight changes on First Amendment grounds (06:58).
    • "If you're going to tell drug makers they can't show people dancing, I think there's a lot to watch here in the coming months and years." – Christina Jewett (08:02)
  • Rulemaking would be slow and susceptible to administrative delays (08:02).

Immigration Policy: H1B Visa Fee Chaos

• Policy Update:

  • The White House clarified that the new $100,000 H1B visa fee for skilled workers applies only to new applications (08:42).
  • Initial confusion led to panic among employers, with urgent messages to employees abroad to return to the U.S. (08:42).
    • "Some employees had demanded to be let off departing flights when messages from their employers hit their phones." – David Brancaccio (08:42)

• Fee Details:

  • After earlier signals it would be an annual fee, it was clarified as a one-time charge (08:42).

Notable Quotes & Moments

• On Bull Market Sentiment:

  • "Our clients still have considerable amount of cash in their accounts... The mood does not seem euphoric." – David Brancaccio (02:34)

• On Ads for Medicine:

  • "He [Kennedy] essentially wants to sort of turn back the clock on this to before 1997..." – Christina Jewett (05:54)
  • "If you're going to tell drug makers they can't show people dancing, I think there's a lot to watch here in the coming months and years." – Christina Jewett (08:02)

• On H1B Visa Chaos:

  • "Some employees had demanded to be let off departing flights when messages from their employers hit their phones." – David Brancaccio (08:42)

Timestamps for Important Segments

• Bull Market Analysis: 01:09 – 03:24
• Pharmaceutical Advertising Crackdown: 05:08 – 08:35
• H1B Visa Fee Confusion: 08:42 – 09:39

Tone and Language

David Brancaccio and his correspondents present the news with a calm, analytical tone. The show is concise, clear, and focuses on delivering immediate, digestible insights for a professional audience.
Speakers' original language is retained, and quotes show a candid, occasionally wry view of market and policy challenges.

Conclusion

This Marketplace Morning Report episode offers a brisk yet in-depth look at the staying power of the current bull market, explains looming regulatory changes in pharma advertising, and unpacks the chaotic implementation of new H1B visa fees. Listeners are left with a sense of cautious optimism on Wall Street, skepticism about regulatory follow-through, and concern over policy uncertainty affecting business and workers alike.